Koers Syneos Health, Inc.
Aandelen
SYNH
US87166B1026
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01-07-23 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28-09-23 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
James Dimitri
BRD | Director/Board Member | - | 28-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.82% | 0 M€ | 0,00% | ||
0.77% | 0 M€ | +8,89% | ||
0.50% | 0 M€ | 0,00% | - | |
0.36% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 47,02 mld. | |
+48,77% | 41,86 mld. | |
+1,17% | 41,76 mld. | |
-4,27% | 28,8 mld. | |
+11,42% | 26,05 mld. | |
-21,39% | 19,15 mld. | |
+4,86% | 12,55 mld. | |
+27,29% | 12,34 mld. | |
-3,50% | 11,82 mld. |